FDA approves Leqselvi for severe alopecia
The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.
Aug 3, 2024
0
1
The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.
Aug 3, 2024
0
1
Many pregnant people have chronic medical conditions, and although they are usually closely monitored during pregnancy, they often face barriers when transitioning to primary care following delivery.
Jul 16, 2024
0
7
An intensive, 12-week pain self-management program has been shown to reduce pain and improve mood in a large clinical trial of people with both HIV and chronic pain. The research, led by University of Pittsburgh physician-scientist ...
Jul 15, 2024
0
0
Decreased sexual desire is the most common sexual complaint among women, affecting 30% to 40% of female adults. What's more, low drive causes significant distress for 7% to 23% of them. The condition, formally called sexual ...
Jul 11, 2024
0
0